Banco Santander SA Hikes Profits By A Third

Profits continue to rise at Banco Santander SA (LON:BNC) — are the gains already in the price, or is the Spanish bank a buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

SantanderBanco Santander (LSE: BNC) (NYSE: SAN.US) delivered another set of impressive quarterly results this morning. The bank said that profits for the first nine months of 2014 rose by 32% to €4.36 billion, while the bank’s non-performing loan ratio fell to 5.28%, down from 5.64% at the end of last year.

Interestingly, Santander’s biggest profit growth came in Spain, where profits for the first nine months of the year rose by 124% to €822m. New loans rose by 1%, and customer funds, such as deposits, were 4% higher.

These Spanish figures compare well to last year, when loans fell by 8%: a rise in loans and an increase in deposits suggests to me that the Spanish economy may be starting to recover, and that customers are no longer drawing down their savings to live on.

In the UK, which is one of Santander’s other main markets, profits rose by 43% to €1,186m during the first nine months, thanks to a 54% rise in current account balances, a 9% increase in loans and a 19% increase in net interest income.

The bank to buy?

I’ve been bullish on Santander for some time and continue to be impressed by the bank’s recovery, its robust balance sheet and its focus on traditional lending and deposit taking activities.

Santander passed the recent European Banking Authority stress tests with flying colours, with a Common Equity Tier 1 ratio of 9% in the worse-case adverse scenario test — compared to just 7.1% at Barclays, for example.

Already in the price?

However, despite Santander’s rising profits, current market forecasts suggest that Santander’s shares may already be fully priced. Today’s 550p share price puts the bank’s shares on a 2014 forecast P/E of 14 and a 2015 P/E of 12 — hardly bargain basement.

What’s more, analysts are persistently bearish about the bank’s oversized dividend, forecasting a small reduction for both this year and next, perhaps because it is not expected to be covered by earnings.

Still a buy for me

According to Reuters, the consensus rating for Santander is hold. However, I’m not convinced: the bank’s management has expressed its commitment to maintaining its annual €0.60 dividend payment, which provides a prospective yield of 8.5% at today’s share price.

I believe Santander continues to deserve a buy rating for long-term income: indeed, along with HSBC Holdings, Santander is my banking pick for income investors.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares in Barclays and HSBC Holdings. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

With £1,000 to invest, should I buy growth stocks or income shares?

Dividend shares are a great source of passive income, but how close to retirement, should investors think about shifting away…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett should buy this flagging FTSE 100 firm!

After giving $50bn to charity, Warren Buffett still has a $132bn fortune. Also, his company has $168bn to spend, so…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing For Beginners

I wish I’d known about this lucrative style of stock market investing 20 years ago

Research has shown that over the long term, this style of investing can generate returns in excess of those provided…

Read more »

Woman using laptop and working from home
Investing Articles

Is this growing UK fintech one of the best shares to buy now?

With revenues growing at 24% and income growing at 36%, Wise looks like one of the best shares to buy…

Read more »

Dividend Shares

Are Aviva shares one of the UK’s best investments today?

UK investors have been piling into Aviva shares recently. However, Edward Sheldon's wondering if he could get bigger returns elsewhere.

Read more »

Older couple walking in park
Investing Articles

10.2% dividend yield! 2 value shares to consider for a £1,530 passive income

Royston Wild explains why investing in these value shares could provide investors with significant passive income for years to come.

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

Read more »

Electric cars charging in station
Investing Articles

Is NIO stock poised for a great rebound?

NIO stock has risen 24.5% over the past month, coming off its lows following a solid month of vehicle deliveries.…

Read more »